- $3.22bn
- $3.22bn
- $2.38bn
- 97
- 59
- 67
- 87
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,077 | 1,191 | 1,536 | 2,167 | 2,377 |
Cost of Revenue | |||||
Gross Profit | 182 | 228 | 288 | 319 | 445 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,035 | 1,141 | 1,451 | 2,111 | 2,217 |
Operating Profit | 41.9 | 50.1 | 85.6 | 56 | 160 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 40.1 | 49.3 | 84.9 | 53 | 159 |
Provision for Income Taxes | |||||
Net Income After Taxes | 33.5 | 40.6 | 68.7 | 40.2 | 120 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 33.2 | 41.6 | 66.7 | 34.8 | 108 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 33.2 | 41.6 | 66.7 | 34.8 | 108 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.56 | 2.24 | 3.16 | 1.66 | 4.91 |